Global Pen Needles Market Size, Share, Drivers, Growth, & Trends Report Segmented by Type (Standard, Safety), Needle Length (4 mm, 5 mm, 6 mm), Application (Insulin Therapy, GLP-1, Growth Hormone), End-user (Hospitals, Clinics) Industry Sales & Regional Analysis, Forecast 2026 to 2031

Pen needles are small, disposable items used with injection pens to deliver medicines such as insulin and other injectable treatments. They have a thin needle fixed to a plastic connector that attaches to the pen before use. Different needle sizes are available so users can select what feels comfortable and suits their injection routine. These needles are made to help deliver the right amount of medicine and make injections easier to handle, especially for people who inject themselves. Pen needles are commonly used both at home and in healthcare facilities. Some types are designed with safety features to help prevent accidental needle injuries.

Shift towards self-administration and home healthcare is driving the market growth

The growing trend toward the use of self-administered products, coupled with the growing demand for home care services, is one of the primary factors driving the growth of the pen needles market. The growing number of people diagnosed with chronic diseases like diabetes, obesity, and hormone deficiencies, will continue to drive this demand, as these patients may receive multiple doses of injectable medications over time. In many cases, getting to the hospital or clinic and waiting for an appointment is burdensome for the patient, and thus, healthcare providers are looking for new ways to provide medications directly to patients in their homes. Pen needles are a good option for people who prefer home injection therapy because they are easy to use and do not require extensive training. They are also compatible with prefilled injection pens, making them much easier to use than a traditional syringe. Since there are fewer steps associated with using a pen needle compared to a traditional syringe, there is a lower likelihood of dosing errors.

Ease of use is even more critical for certain populations like older adults, young children, and those with limited dexterity who comprise a large portion of those with chronic illnesses. As demand for home healthcare services increases, so does the demand for this type of product. When patients have access to home-based healthcare, they are less likely to visit the hospital and lower overall healthcare costs, which leads to improved long-term disease management for patients. In addition, pen needles support home healthcare by allowing patients to continue their regular therapy without the need for interaction with their healthcare professional for every injection. Increased independence enhances adherence to a prescribed treatment regimen, and adherence to a prescribed diabetic treatment is essential since not taking medication as directed or not taking the right dosage can result in serious complications.

The continued use of telemedicine and remote patient monitoring by physicians has been a major factor for the shift toward patient self-management of their health. The physicians increasingly prescribe injectable medications with specific instructions for use at home, and the pen needle is now incorporated into most injectable treatment plans. New product developments for pen needles have been made by manufacturers. Manufacturers are designing pen needles to be shorter, thinner, and easier to hold and inject comfortably. Furthermore, the growing number of people using insulin for diabetes is a result of improved patient acceptance of self-injection through the development of new pen needle technology.

The growing awareness of infection prevention has also contributed to the transition to self-administration. Pen needles designed for one use only decrease the risk of contamination and the transmission of infectious diseases to the home and other settings in which medication is administered. Safety-engineered designs also provide protection to patients and caregivers from accidental needle stick injuries, which is extremely important in environments where medications are administered outside of a hospital or other clinical setting. With the continued shift toward self-administration of medications and at-home health care, manufacturers are converting pen needles from a tool used to assist health care providers in the treatment of patients to a necessary consumable product in the treatment of patients. As health care systems continue to emphasize a patient-centered approach and increasing numbers of people can manage their own health, the use of pen needles will continue to rise and the demand for pen needles will continue to increase consistently and steadily.

To learn more about this report, download the PDF brochure

Integration with digital health / smart pen systems – a key market trend

The integration of digital health and smart pen systems represents a rapidly growing trend within the pen needle industry to help alleviate issues associated with managing chronic illnesses such as diabetes or hormonal diseases, where dosages need to be accurate and monitored frequently. In addition, many traditional manual injectors don't allow for easy tracking of how much medication has been injected, which can result in missing doses or taking the wrong dose.

As such, connected pen systems and smart pens are designed to keep accurate records of each injection's date, time, and dosage amount, which will assist both patient users and their corresponding healthcare providers. Connected pen systems integrate with mobile applications, allowing patients to track their progress, receive reminders to inject, and get feedback. This capability promotes greater adherence to their prescribed regimen. Furthermore, the availability of updated injection information enables physicians to be better equipped to make educated decisions about dosage changes and/or treatment alterations. Lastly, smart pen technology supports remote patient monitoring via telemedicine as more patients receive care in the comfort of their own home versus travel to the office of their physician.

The development of electronic pen needles and electronic pens that communicate with digital health platforms creates a seamless experience for chronic disease sufferers through the integration of various applications and devices. Some smart pen systems allow for wirelessly transmitting data from the smart pens to healthcare providers, which increases accuracy in the delivery of medication, reduces errors by patients, and enhances the patient experience regardless of their age. Along with the introduction of new technologies, such as smart pens with a Bluetooth connection, a medical prescription is required for a patient to receive their injections. This allows for seamless communication, which further enhances the value of a smart pen system. The increasing emphasis on patient-centered care, combined with the many technological improvements in the design of medical devices, also contribute to the rapid adoption of digital health-enabled pen needles. In addition to this, the available safety features, including auto-shielding needles, can be combined with smart pens and devices to protect against injury and to track the patient's injection use.

Overall, the integration of digital health and smart pen systems into the pen needles market will ultimately change the way patients manage and administer their injectable therapies. By providing patients with increased convenience, increased accuracy, and access to real-time data, the growing adoption of digital health-enabled pen needles will not only improve compliance with approved treatment protocols but will also help accelerate the growth of the pen needles market. The trend towards connected healthcare systems and patient-centered solutions will allow smart pen systems to become a more significant factor in the growing pen needle market.

To learn more about this report, download the PDF brochure

Type Segment Outlook

Standard pen needles dominate the pen needle market due to their extensive use, affordability, and high levels of acceptance by patients using them for home care. In addition, standard pen needles are recommended for people that receive regular insulin and injectable drugs, for example, those residing in regions with low healthcare costs, which explains the sheer volume of demand for these types of needles. Unlike standard pen needles, safety pen needles are the fastest-growing segment of the overall pen needle market because of a larger awareness of occupational needle stick injuries, changes in government safety regulations regarding employment within some healthcare facilities, and improvements in the manufacturing process for safety pen needles. Unlike standard pen needles, safety pen needles offer built-in safety protection features which encourage their use in hospitals and clinics, but also in home healthcare situations with elderly/high-risk individuals.

Regional Outlook: North America expected to hold a major share in the pen needles market

North America leads in terms of market size for the pen needle market. Major factors contributing to the high growth rate including a high prevalence of diabetes; reimbursement policies that cover the cost of pen needles; and the increased use of insulin pen technology and new advanced pen needle technology. The next largest region is Europe, mainly due to established healthcare systems with increased emphasis on patient safety. In contrast, the Asia Pacific region has the fastest growth; the rapid increase in this region's diabetic population coupled with increased access to healthcare and improved consumer awareness regarding self-administration of medication and home care has driven the growth of the Asia Pacific market. Expanding distribution networks and rising healthcare expenditures in countries like China and India continue to drive market growth for the region.

Competitive Landscape Analysis

The global pen needles market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company (BD) (US); Novo Nordisk A/S (Denmark); Ypsomed AG (Switzerland); B. Braun SE (Germany); Owen Mumford (UK); Terumo Corporation (Japan); NIPRO Corporation (Japan); Allison Medical, Inc. (US); Trividia Health, Inc. (US); and UltiMed, Inc. (US); among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.

Get a sample report for competitive landscape analysis

Recent developments in the pen needles market

Players operating in this market are adopting different growth strategies such as new product launches and acquisitions to garner market share. For instance,

• In October 2025, Sandstone Medical launched its Easydrip Plus pen needles in Turkey, featuring a patent-protected hexagonal hub designed to improve grip, stability, and injection comfort. The ISO 13485 and CE-certified product is being distributed through a nationwide pharmacy network, positioning it as a mid-range alternative between premium brands and low-cost generics and drawing interest from nearby Middle East markets
• In August 2025, Trividia Health launched its TRUEplus five-bevel insulin pen needles in the UK, marking the product’s first availability outside the US. The new range offers multiple needle sizes at a lower cost, aiming to improve injection comfort and expand access to affordable, high-quality pen needles for diabetes care
• In November 2024, Evercare launched a new range of pen needles designed to improve comfort and safety for people with type I diabetes using insulin pens. The product features a flat needle base to reduce intramuscular injection risk, improved grip for easier handling, and a safer cap design to help prevent accidental needlestick injuries
• In August 2024, MTD Group acquired Ypsomed’s Pen Needles and Blood Glucose Monitoring businesses, strengthening its position in diabetes and obesity care. The deal makes MTD the world’s second-largest pen needle player, expanding European production capacity to over 2.5 billion pen needles annually

Report Scope

Global Pen needles Market Segmentation

This report by Medi-Tech Insights provides the size of the global Pen needles market at the regional- and country-level from 2024 to 2031. The report further segments the market based on type, needle length, application, and end user.

Market Size & Forecast (2024-2031), By Type, USD Billion

• Standard Pen Needles
• Safety Pen Needles

Market Size & Forecast (2024-2031), By Needle Length, USD Billion

• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 10 mm
• 12 mm

Market Size & Forecast (2024-2031), By Application, USD Billion

• Insulin Therapy
• GLP-1 Therapy
• Growth Hormone Therapy
• Other Applications

Market Size & Forecast (2024-2031), By End-user, USD Billion

• Home Care Settings
• Hospitals and Clinics
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Related Reports:

Diabetes Devices Market Size, Share & Growth Analysis, by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-use) and Regional Forecast to 2031

Global Injection Pen Market Size & Trends Report Segmented by Type (Disposable, Reusable), Application (Diabetes, Growth Hormone Therapy, Fertility, Autoimmune Diseases, Cancer), End User (Hospitals, ASCs, Home Care Settings) & Regional Forecast to 2030

Global Insulin Delivery Device Market Size & Trends Report Segmented by Product Type (Pens, Pumps, Needles, Syringes), Disease Type (Type 1 and 2), End-user (Hospitals, Clinics, Homecare Settings) Industry Analysis & Regional Forecast to 2030